Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Commission on Professional and Hospital Activities | 1 | 2019 | 4 | 0.83 | Why? |
| Psychology, Child | 1 | 2021 | 206 | 0.76 | Why? |
| Asthma | 7 | 2020 | 4383 | 0.67 | Why? |
| Neonatology | 1 | 2015 | 84 | 0.57 | Why? |
| Child Welfare | 1 | 2020 | 405 | 0.56 | Why? |
| Cystic Fibrosis | 3 | 2019 | 1104 | 0.55 | Why? |
| Child Health | 2 | 2020 | 940 | 0.53 | Why? |
| Anti-Asthmatic Agents | 1 | 2019 | 427 | 0.53 | Why? |
| Domestic Violence | 1 | 2020 | 522 | 0.52 | Why? |
| Respiratory Tract Diseases | 1 | 2021 | 1061 | 0.49 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.47 | Why? |
| Health Planning | 1 | 2019 | 607 | 0.46 | Why? |
| Food Supply | 1 | 2020 | 1027 | 0.45 | Why? |
| Poverty | 1 | 2020 | 2302 | 0.36 | Why? |
| Quality of Health Care | 1 | 2019 | 1948 | 0.34 | Why? |
| State Medicine | 1 | 2019 | 2847 | 0.30 | Why? |
| Vulnerable Populations | 1 | 2020 | 3099 | 0.30 | Why? |
| Biological Products | 1 | 2019 | 2331 | 0.27 | Why? |
| Mental Health Services | 1 | 2021 | 3007 | 0.26 | Why? |
| United Kingdom | 6 | 2020 | 18046 | 0.26 | Why? |
| Child | 18 | 2021 | 70012 | 0.25 | Why? |
| Bone Nails | 2 | 2018 | 18 | 0.24 | Why? |
| Health Status Disparities | 1 | 2020 | 4072 | 0.24 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3832 | 0.23 | Why? |
| Fracture Fixation, Intramedullary | 2 | 2018 | 44 | 0.23 | Why? |
| Irritable Mood | 1 | 2021 | 93 | 0.22 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.19 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.19 | Why? |
| Mucociliary Clearance | 1 | 2019 | 72 | 0.19 | Why? |
| Saline Solution, Hypertonic | 1 | 2019 | 81 | 0.19 | Why? |
| Research Design | 1 | 2015 | 5830 | 0.18 | Why? |
| Theophylline | 1 | 2018 | 39 | 0.18 | Why? |
| Bone Screws | 1 | 2017 | 30 | 0.18 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2018 | 10649 | 0.18 | Why? |
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2018 | 113 | 0.17 | Why? |
| Aminophylline | 1 | 2017 | 4 | 0.17 | Why? |
| Codon, Nonsense | 1 | 2017 | 66 | 0.17 | Why? |
| Oxadiazoles | 1 | 2017 | 41 | 0.17 | Why? |
| Administration, Intravenous | 2 | 2018 | 1115 | 0.16 | Why? |
| Omalizumab | 1 | 2019 | 158 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Parents | 2 | 2020 | 2758 | 0.15 | Why? |
| Traumatology | 1 | 2018 | 255 | 0.15 | Why? |
| Nails | 1 | 2017 | 143 | 0.15 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.14 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.14 | Why? |
| Mental Health | 1 | 2021 | 15770 | 0.14 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2021 | 846 | 0.13 | Why? |
| Genetic Therapy | 1 | 2018 | 409 | 0.13 | Why? |
| Review Literature as Topic | 1 | 2017 | 387 | 0.13 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.13 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.12 | Why? |
| Drug Monitoring | 2 | 2017 | 1408 | 0.12 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2021 | 1234 | 0.11 | Why? |
| Bronchodilator Agents | 1 | 2017 | 444 | 0.11 | Why? |
| Lung | 1 | 2020 | 31049 | 0.11 | Why? |
| Hypersensitivity | 1 | 2021 | 1137 | 0.11 | Why? |
| Humans | 27 | 2021 | 930598 | 0.11 | Why? |
| Double-Blind Method | 2 | 2019 | 5988 | 0.11 | Why? |
| Program Evaluation | 1 | 2019 | 1929 | 0.11 | Why? |
| Adolescent | 9 | 2021 | 86841 | 0.11 | Why? |
| Environmental Exposure | 1 | 2020 | 1558 | 0.10 | Why? |
| Child, Preschool | 5 | 2020 | 36283 | 0.10 | Why? |
| Bias | 1 | 2015 | 1109 | 0.10 | Why? |
| Acute Disease | 2 | 2019 | 6029 | 0.09 | Why? |
| Simulation Training | 1 | 2018 | 957 | 0.09 | Why? |
| Social Determinants of Health | 1 | 2020 | 1757 | 0.09 | Why? |
| Multicenter Studies as Topic | 1 | 2015 | 2437 | 0.09 | Why? |
| Evidence-Based Medicine | 2 | 2020 | 3228 | 0.09 | Why? |
| Chronic Disease | 1 | 2021 | 5139 | 0.08 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.07 | Why? |
| Education, Medical, Undergraduate | 1 | 2018 | 1392 | 0.07 | Why? |
| Schools | 1 | 2020 | 4187 | 0.07 | Why? |
| Developing Countries | 1 | 2020 | 4283 | 0.07 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.07 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.06 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.06 | Why? |
| Pharmaceutical Preparations | 1 | 2017 | 1897 | 0.06 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.06 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.06 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.05 | Why? |
| Phenylbutyrates | 1 | 2018 | 2 | 0.05 | Why? |
| Teaching Materials | 1 | 2018 | 14 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Aminophenols | 1 | 2018 | 22 | 0.05 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.05 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.05 | Why? |
| Psychomotor Performance | 1 | 2018 | 110 | 0.04 | Why? |
| Benzodioxoles | 1 | 2018 | 78 | 0.04 | Why? |
| Tobacco Smoke Pollution | 1 | 2020 | 181 | 0.04 | Why? |
| Masks | 1 | 2020 | 8528 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Tobramycin | 1 | 2017 | 18 | 0.04 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.04 | Why? |
| Aminopyridines | 1 | 2018 | 121 | 0.04 | Why? |
| Dose-Response Relationship, Drug | 2 | 2017 | 3776 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2021 | 10697 | 0.04 | Why? |
| Spirometry | 1 | 2020 | 524 | 0.04 | Why? |
| Communicable Disease Control | 3 | 2021 | 29620 | 0.04 | Why? |
| Kenya | 1 | 2020 | 887 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 9335 | 0.04 | Why? |
| Male | 8 | 2020 | 367725 | 0.04 | Why? |
| Quinolones | 1 | 2018 | 167 | 0.04 | Why? |
| Depression | 1 | 2021 | 14116 | 0.04 | Why? |
| Female | 8 | 2020 | 380317 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Anxiety | 1 | 2021 | 17311 | 0.04 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.03 | Why? |
| Infant | 3 | 2020 | 30274 | 0.03 | Why? |
| Cost-Benefit Analysis | 1 | 2020 | 2259 | 0.03 | Why? |
| Indoles | 1 | 2018 | 1243 | 0.02 | Why? |
| Hip Fractures | 1 | 2017 | 667 | 0.02 | Why? |
| Cognition | 1 | 2018 | 1394 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.02 | Why? |
| Seasons | 1 | 2020 | 4071 | 0.02 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 1261 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.02 | Why? |
| Phylogeny | 1 | 2021 | 13341 | 0.01 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
| Students, Medical | 1 | 2018 | 4032 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Adult | 3 | 2018 | 244371 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.01 | Why? |
| Middle Aged | 2 | 2018 | 270681 | 0.01 | Why? |
Sinha's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(101)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_